Description

Abciximab Injection is a glycoprotein IIb/IIIa inhibitor used to prevent blood clots during percutaneous coronary interventions. It works by blocking platelet aggregation, reducing the risk of cardiovascular events, and improving outcomes in patients undergoing procedures like angioplasty or stent placement.